LivaNova PLC Share Price London S.E.
Equities
LIVN
GB00BYMT0J19
Medical Equipment, Supplies & Distribution
Sales 2024 * | 1.22B 95.56B | Sales 2025 * | 1.28B 100B | Capitalization | 3.32B 261B |
---|---|---|---|---|---|
Net income 2024 * | 39M 3.07B | Net income 2025 * | 91M 7.15B | EV / Sales 2024 * | 2.65 x |
Net cash position 2024 * | 102M 8.03B | Net cash position 2025 * | 231M 18.13B | EV / Sales 2025 * | 2.42 x |
P/E ratio 2024 * |
89.1
x | P/E ratio 2025 * |
35.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.87% |
Latest transcript on LivaNova PLC
Managers | Title | Age | Since |
---|---|---|---|
Alex Shvartsburg
DFI | Director of Finance/CFO | 54 | 31/12/16 |
William Kozy
CHM | Chairman | 72 | 11/06/18 |
Matt J. Dodds
CTO | Chief Tech/Sci/R&D Officer | - | 07/01/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 02/12/20 | |
Peter Wilver
BRD | Director/Board Member | 64 | 12/06/22 |
William Kozy
CHM | Chairman | 72 | 11/06/18 |
1st Jan change | Capi. | |
---|---|---|
-6.23% | 180B | |
+2.59% | 112B | |
-2.75% | 68.53B | |
+5.32% | 51.97B | |
+7.61% | 44.08B | |
+5.62% | 42.23B | |
+25.17% | 32.43B | |
+16.72% | 26.39B | |
-2.66% | 24.97B |